|
SEL1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00209995856915E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.43059999963202E-07 |
| Normal-vs-Stage2 |
2.024500E-03 |
| Normal-vs-Stage3 |
4.13002965160558E-14 |
| Normal-vs-Stage4 |
1.27370003433214E-09 |
| Stage1-vs-Stage2 |
3.332600E-01 |
| Stage1-vs-Stage3 |
1.281430E-03 |
| Stage1-vs-Stage4 |
3.394000E-02 |
| Stage2-vs-Stage3 |
6.917000E-03 |
| Stage2-vs-Stage4 |
1.424190E-02 |
| Stage3-vs-Stage4 |
9.335200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.2676973066591E-13 |
| Normal-vs-AfricanAmerican |
3.68719999999101E-06 |
| Normal-vs-Asian |
1.37549999945641E-07 |
| Caucasian-vs-AfricanAmerican |
9.377800E-01 |
| Caucasian-vs-Asian |
6.884400E-01 |
| AfricanAmerican-vs-Asian |
7.157400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.04259975389709E-11 |
| Normal-vs-Female |
2.70229999488336E-08 |
| Male-vs-Female |
1.052380E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.70619999976196E-07 |
| Normal-vs-Age(41-60Yrs) |
1.57810431389294E-11 |
| Normal-vs-Age(61-80Yrs) |
3.0242999993213E-08 |
| Normal-vs-Age(81-100Yrs) |
3.898200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.347190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.883000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.294400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.530600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.041400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.206800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.829800E-04 |
| Classical-VS-Follicular |
2.923900E-02 |
| Classical-VS-Other |
1.533220E-01 |
| Classical-VS-Normal |
4.43659553539533E-11 |
| Tall-VS-Follicular |
2.48989999999116E-05 |
| Tall-VS-Other |
9.069800E-01 |
| Tall-VS-Normal |
7.85482789922298E-13 |
| Follicular-VS-Other |
1.147640E-02 |
| Follicular-VS-Normal |
4.962800E-03 |
| Other-VS-Normal |
1.574920E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.08019999944808E-07 |
| Normal-vs-N1 |
4.98480146049474E-11 |
| N0-vs-N1 |
4.763100E-03 |
|
|
